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Purpose: We previously reported that certain mitochondrial DNA (mtDNA) polymorphisms in the coding region may be
involved in the pathogenesis for primary open-angle-glaucoma (POAG). This encouraged us to extend our work and assess
whether mtDNA diagnostic polymorphisms, defining geographically structured haplogroups, could be associated with
the development of POAG.
Methods: We sequenced the mtDNA regulatory hypervariable region-I (HVS-I) region and coding regions, comprising
haplogroup diagnostic polymorphisms, in 176 POAG patients and 186 matched healthy controls (free of glaucoma by
examination) of Saudi Arabia ascendancy. A large sample of 810 healthy Saudi Arabs representing the general Saudi
population has also been included in the analysis. Assigning individuals into various mitochondrial haplogroups was
performed using the nomenclature previously described for African and for Eurasian sequences.
Results: African mtDNA haplotypes belonging to L haplogroups, excluding L2, confer susceptibility to POAG whereas
the Eurasian haplogroup N1 was associated with reduced risk of developing POAG in Saudi Arabian population.
Conclusions: Saudi individuals with mtDNA of African origin are at higher risk of developing POAG. In addition, the
mtDNA Eurasian haplogroup N1 may play a mild protective effect to this illness.
The term glaucoma comprises a heterogenous group of
ocular disorders characterized by progressive retinal ganglion
cell death, optic nerve atrophy and different patterns of visual
field loss. There are two types of primary glaucoma: Primary
open-angle-glaucoma  (POAG),  and  primary  angle-closure
glaucoma  (PACG).  POAG  is  the  most  common  type
worldwide accounting for majority of glaucoma cases [1].
Older age, positive family history, age, black race, myopia,
diabetes,  hypertension,  and  elevated  ocular  pressure  have
been  identified  as  important  risk  factors  for  POAG.  The
prevalence  of  POAG  in  Saudi  Arabia  is  unknown.  The
Glaucoma  unit  at  King  Abdulaziz  University  Hospital
(KAUH), where approximately 600 new glaucoma patients
are seen annually (as indicated by an ongoing study on the
pattern of glaucoma at KAUH for the period from 2006 to
2010), has found that 19% of those are POAG, 40% primary
angle-closure  glaucoma,  10%  have  pseudoexfoliation
glaucoma,  and  the  remaining  31%  are  other  types  of
glaucoma. It seems that racial and sex influences depend on
the type of glaucoma. POAG has been reported with higher
prevalence in African and men [2] and PACG in Asians and
women [3]. Primary glaucoma is also heterogeneous in its
hereditable basis. Although rare forms of juvenile glaucoma
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may be caused by single gene mutations, the majority of cases
are better explained by a confluence of complex genotype and
environmental risk factors [4,5]. It has also been suggested
that,  similar  to  other  optic  nerve  atrophies,  mitochondrial
dysfunction or altered mitochondrial signaling pathways are
involved in the glaucoma pathogenesis [6,7]. In a recent article
on POAG in Saudi Arabia [8], no pathological nucleotide
changes  were  detected  for  the  autosomic  causative  genes
myocilin (MYOC) and optineurin (OPTN). Conversely, the
number  of  nonsynonymous  mutations  and  transversions
found in the mitochondrial DNA (mtDNA) coding region of
POAG  patients  was  significantly  greater  than  in  control
subjects. In addition, mean mitochondrial respiratory activity
was  decreased  by  21%  in  POAG  patients  compared  with
control subjects. Although no individual mutations could be
associated  with  POAG,  these  data  suggested  that
mitochondrial dysfunction may be a risk factor for this disease
and were in accordance with previous epidemiological studies
showing that the prevalence of a positive maternal family
history of POAG patients was significantly greater than on the
paternal  side  [9].  Due  to  its  maternal  inheritance,  high
mutation rate and lack of recombination mtDNA shows a
distinct picture of female human dispersion, resulting in the
distribution of its lineages into continent specific haplogroup.
These haplogroups are defined by diagnostic polymorphisms
present in the mtDNA coding and regulatory regions. Thus,
at the broadest level, mtDNA sequences belonging to macro-
haplogroup L had an African origin and those belonging to
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1468macro-haplogroups M and N had a Eurasian origin. There are
numerous reports associating mtDNA haplogroups to various
diseases including optic neuropathies [10]. The aim of the
present  study  was  to  assess  the  possible  role  of  mtDNA
haplogroups in POAG among Saudi patients.
METHODS
Patients and control subjects: We recruited 176 Saudi POAG
patients who satisfied strict clinical criteria for POAG which
includes the following: i) appearance of the disc or retinal
nerve  fiber  layer  e.g.,  thinning  or  notching  of  disc  rim,
progressive changes, nerve fiber layer defect; ii) the presence
of characteristic abnormalities in visual field (e.g., arcuate
scotoma,  nasal  step,  paracentral  scotoma,  generalized
depression) in the absence of other causes or explanation; iii)
age greater than 40 years, and iv) open anterior chamber
angles bilaterally on gonioscopy. Exclusion criteria included
evidence of secondary glaucoma, e.g., pigmentary dispersion
syndrome, pseudoexfoliation, history of steroid use, or ocular
trauma. All cases had onset of glaucoma after age 40 (adult-
onset  POAG).  Patients  were  recruited  from  the  glaucoma
clinic at KAUH after signing an informed consent approved
by the institutional review board (proposal number # 08–657).
A second group (n=186) of healthy Saudi Arabs controls
(HMC  group)  free  from  glaucoma  by  examination  were
recruited.  Entry  criteria  for  those  subjects  were  age  >40,
normal IOP, open angles on gonioscopy, and normal optic
nerves upon examination.
A third large sample (n=810) of healthy Saudi Arabs
(HSA), representing all five major Saudi Arabian provinces,
that were recruited previously for population genetics studies,
was used for statistical comparisons. All individuals of this
group  were  Saudi  Arabs  who  reported  no  symptomatic
metabolic,  genetic,  ocular  disorders  or  any  ophthalmic
problem  on  an  extensive  questionnaire  regarding  family
history, past medical problems, and current health. For those
controls, their mother’s ancestral origin was established as a
Saudi. The mtDNA haplogroup assignation for 552 subjects
of this sample has been already published [11]. All patients
and controls were maternally unrelated Saudi Arabs, all whose
known ancestors were of Saudi Arabian origin. This research
followed the tenets of the Declaration of Helsinki.
DNA  extraction:  Five  milliters  of  peripheral  blood  were
collected in EDTA tubes from all participating individuals.
DNA was extracted using the illustra blood genomicPrep Mini
Spin Kit from GE Healthcare (Buckinhamshire, UK), and
stored at –20 °C in aliquots until required.
Mitochondrial  haplogroup  assortment:  All  samples  were
amplified and sequenced for the mtDNA regulatory region
hypervariable  segments  (HVSs)  I  and  II  using  previously
described  primers  and  conditions  [12].  Haplotypes  were
tentatively assorted into haplogroups according to their HVS
diagnostic positions. This assortment was further confirmed,
when necessary, by the analysis of coding-region diagnostic
haplogroup  polymorphisms  (Table  1),  following  the  most
recent mtDNA haplogroup nomenclature [13]. To detect these
polymorphisms a fragment spanning the diagnostic position
was amplified and sequenced using any of the 32 overlapping
pairs of primers that cover the whole mtDNA genome, and the
PCR and sequencing conditions previously published for each
of them [12].
Statistical  analysis:  Haplogroup  frequency  differences
between patient and control cohorts were tested by pair-wise-
exact tests of sample differentiation [14] using the Arlequin
3.11  package.  The  frequency  of  determined  haplogroups,
between cases and controls were compared with the ÷2 test or
with  Fisher’s  exact  tests  when  appropriate.  To  keep
statistically  adequate  haplogroup  sub-sample  sizes  within
cohorts, when necessary, mtDNA haplogroups were collapsed
into larger haplogroup identities following a phylogenetic
criterion [13].
RESULTS
Haplogroup  frequencies  obtained  for  the  POAG  patients,
healthy matched controls (HMC) and the general Saudi Arab
population (HSA) are listed in Table 1. Pair-wise exact tests
between  cohorts,  based  on  total  haplogroup  frequencies,
showed that HMC and HSA controls are homogenous groups
(p=0.516).  On  the  other  hand,  the  POAG  cohort  differs
significantly  (p=0.028)  from  HSA  controls  only.  A
haplogroup by haplogroup inspection (Table 1) shows that
haplogroup L frequency (0.216) and, in less degree, to the N1
(0.045) frequency in POAG as the most different from HSA
controls  (0.117  and  0.081,  respectively).  In  fact,  ÷2  test
analysis confirmed that haplogroup L was in a significant
excess (p=0.001) and haplogroup N1 in a significant decrease
(p=0.04) in POAG compared to the HSA group. Furthermore,
matched controls HMC also presents a significant decrease of
L haplotypes (0.129) compared to POAG (p=0.03) and have,
comparatively, more N1 haplotypes (0.07) although without
reaching  significance  (p=0.250).  These  data  could  be
interpreted as that, the African haplogroup L is associated with
the risk of developing POAG while the Eurasian haplogroup
N1 could have a mild protective effect on this illness.
DISCUSSION
From the results obtained here, it can be deduced that there is
a  POAG  predisposition  in  those  Saudi  individuals  with
mtDNA  of  African  ancestry.  The  significantly  greater
susceptibility to POAG in subjects with African ascendance
compared  to  those  with  Eurasian  ascendance,  in  other
geographical areas, has been well documented [2,15]. Our
results  are  congruent  with  the  lack  of  differences  in  the
haplogroup distribution between POAG patients and healthy
controls in a study performed on white people from England
[16] as they did not analyzed the sub-Saharan African segment
of  the  English  population.  They  could  also  satisfactorily
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1470explain  the  higher  number  of  mtDNA  non-synonymous
mutations found in POAG Saudi patients when compared with
healthy  individuals  found  in  a  previous  mtDNA  genomic
analysis [8]. All the sequences are compared to the revised
Cambridge  reference  sequence  (rCRS)  [17],  that  is  an
Eurasian  sequence  and,  therefore,  more  phylogenetically
related to other Eurasian sequences than to the L African
sequences [13]. Now, we know that the frequency of African
haplogroups in POAG is significantly greater than in controls
so, it is logical that a higher number of mutations were found
in  the  POAG  group  compared  to  the  control  group.
Furthermore, several of the mtDNA coding region mutations
found in Saudi POAG patients in that study, have been found
in Sub-Saharan African complete sequences. These results
illustrate  the  convenience  of  knowing  the  haplogroup
background  of  individual  mitochondrial  variants  with
significant association to diseases because, as in our case, it
could unveil unknown racial risk factors for those diseases or
unexpected population substructure. It is also well known that
other  ethnic  groups  are  more  propense  to  other  types  of
glaucoma. In the case of the Saudi Arabian population, it has
been recently found that patients with haplotypes belonging
to the mtDNA haplogroup R0a are at higher risk of developing
PACG [18]. As R0a is a Eurasian haplogroup, this result is
also in agreement with the higher predisposition found for
PACG in Asians. Both results confirm, in Saudi Arabia, that
multi-ethnic populations have different human groups with
different  illness  predispositions.  Even  when  there  are  not
behavioral barriers among groups, as the mtDNA is a non-
recombining molecule, the original ethnic maternal ancestry
of  an  individual  can  be  easily  detected  and  its  influence
evaluated independently of its nuclear genome background.
In  our  samples,  the  mtDNA  variant  16189T>C  has  a
frequency  significantly  greater  (p<0.000)  in  African
haplogroups  (0.38)  than  in  Eurasian  haplogroups  (0.18).
Frequently, this polymorphism has been found associated to
different  diseases,  including  coronary  artery  disease  and
myocardial infarction in Saudi Arabs [19], but it seems not to
play  a  particular  role  in  POAG.  First,  the  frequency
differences  of  16189  between  POAG  and  control  cohorts
HMC or HSA did not reach significance (p=0.24 and p=0.12,
respectively).  Second,  within  African  haplogroups,  the
frequency of 16189 in POAG (0.39) is strikingly similar to
that in HNC (0.39) or HSA (0.37) and the same happens when
its  frequency,  within  Eurasian  haplogroups,  is  compared
between the same cohorts (0.21, 0.17, and 0.17, respectively).
In  a  parallel  association  study  involving  mtDNA  and
pseudoexfoliation glaucoma (PEG) in Saudi Arabia [20], we
found  that  the  African  mtDNA  haplogroup  L2  and  the
Eurasian haplogroup T confer susceptibility to PEG whereas
the Eurasian haplogroup N1 was associated with reduced risk
to develop that illness. At first sight, these results are strikingly
similar to those found in the present study: the African macro-
haplogroup L and the Eurasian N1 were found respectively
associated with susceptibility and reduced risk to POAG. On
its side, haplogroup T has also a lower frequency in POAG
(0.03) than in both HMC (0.05) and HSA (0.07) controls,
although differences did not reach a significant level (p=0.50
and  p=0.11,  respectively).  Moreover,  these  analogous
mtDNA associations in POAG and PEG coincide with another
recent  study  reporting  that  mitochondrial  damage  in  the
trabecular  meshwork  occurs  only  in  these  two  forms  of
glaucoma [7]. However, the association found between PEG
and L haplotypes was specifically with those belonging to
haplogroup L2, whereas the one found here involves different
L haplotypes as there is a lack of specific association between
POAG and haplogroup L2 when compared to HMC (p=0.72)
and  HAS  (p=0.27)  controls.  Differences  in  co-adaptation
between  mitochondrial  and  nuclear  genomes  might  be
responsible of this difference. There is increasing information
about the role of mitochondria in the development of POAG
[6,21].  It  seems  that  mtDNA  polymorphisms,  defining
haplogroups are also involved in this process. However, to
unveil the genetic and physiologic causes of these associations
further research is needed.
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